CAS: | 334827-98-4 | ||||
分子式: | C29H39N7O8S2 | ||||
分子量: | 677.79 | ||||
英文名称: |
| ||||
用途: | Gisadenafil besylate (UK 369003-26) is a specific, orally active phosphodiesterase 5 (PDE5) inhibitor (IC50, 3.6 nM). Gisadenafil besylate inhibits cyclic guanosine monophosphate (cGMP) degradation. |
货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||||||||||||||||||||
G912361 | MACKLIN | Gisadenafil besylate (UK 369003-26) | ≥98% | 1264元/1mg; | 展开 | ||||||||||||||||||||||||||||||||||||||||||
储存:-20°C,密闭,干燥 | |||||||||||||||||||||||||||||||||||||||||||||||
PZ0172 | Sigma-Aldrich | Gisadenafil besylate salt | ≥98% (HPLC) | 1364.72元/5 MG; 5158.2元/25 MG; | 展开 | ||||||||||||||||||||||||||||||||||||||||||
产品说明 包装 5, 25 mg in glass bottle 生化/生理作用 Gisadenafil (UK 369003) is a PDE5 inhibitor. It is 80 fold selective over PDE6, and greater than 3000 fold selective over PDEs 1-4 and 7. 特点和优势 This compound is featured on the Phosphodiesterases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. 其他说明 This compound was developed by Pfizer for Cyclic Nucleotides research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer. 法律信息 Sold for research purposes under agreement from Pfizer Inc. 基本信息
产品性质
安全信息
|